Effect of FK506 in reducing scar formation by inducing fibroblast apoptosis after sciatic nerve injury in rats

Cell Death and Disease

Volumn 4, Issue 3, 2013, Pages

  Que, J ^a   Cao, Q ^a   Sui, T ^a   Du, S ^a   Kong, D ^a   Cao, X ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell signaling; Fibroblast; FK506; Scar formation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CHOLECYSTOKININ OCTAPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TACROLIMUS; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; CASPASE 3; CYTOCHROME C; FLAVONOID; IMMUNOSUPPRESSIVE AGENT; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL PROTECTION; CELL SUSPENSION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MALE; NERVE ANASTOMOSIS; NERVE CELL INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCAR FORMATION; SCIATIC NERVE INJURY; SKIN FIBROBLAST; SPRAGUE DAWLEY RAT; TREATMENT DURATION; ANASTOMOSIS; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; FIBROBLAST; INJURY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SCAR; SCIATIC NERVE;

RATTUS;

ANASTOMOSIS, SURGICAL; ANIMALS; ANTHRACENES; APOPTOSIS; CASPASE 3; CELL PROLIFERATION; CELLS, CULTURED; CICATRIX; CYTOCHROMES C; CYTOPROTECTION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FLAVONOIDS; IMMUNOSUPPRESSIVE AGENTS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; TACROLIMUS;

MLCS; MLOWN;

EID: 84875874307     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.56     Document Type: Article

References (37)

1. Sosa I, Reyes O, Kuffler DP. Immunosuppressants: Neuroprotection and promoting neurological recovery following peripheral nerve and spinal cord lesions. Exp Neurol 2005; 195: 7-15.
2. Rustemeyer J, Dicke U. Allografting combined with systemic FK506 produces greater functional recovery than conduit implantation in a rat model of sciatic nerve injury. J Reconstr Microsurg 2010; 26: 123-129.
3. Graham WP, Pataky PE, Calabretta AM, Munger BL, Buda MJ. Enhancement of peripheral nerve regeneration with triamcinolone after neurorrhaphy. Surg Forum 1973; 24: 457-459.
4. Lane JM, Bora FW, Pleasure D. Neuroma scar formation in rats following peripheral nerve transection. J Bone Joint Surg Am 1978; 60: 197-203.
5. Sunderland S. Nerve and Nerve Injury. Churchill Livingstone: New York, 1987. pp 173-176.
6. Atkins S, Smith KG, Loescher AR, Boissonade FM, O'Kane S, Ferguson MW et al. Scarring impedes regeneration at sites of peripheral nerve repair. Neuroreport 2006; 17: 1245-1249.
7. Bora FJ. Peripheral nerve repair in cats. The fascicular stitch. J Bone Joint Surg 1967; 49: 659-666.
8. Yan Y, Sun HH, Hunter DA, Mackinnon SE, Johnson PJ. Efficacy of short-term FK506 administration on accelerating nerve regeneration. Neurorehabil Neural Repair 2012; 26: 570-580.
9. Jifeng H, Dezhong L, Qiongjiao Y, Huayong Z, Shipu L. Evaluation of PRGD/FK506/NGF conduits for peripheral nerve regeneration in rats. Neurol India 2010; 58: 384-391.
10. Li X, Wang W, Wei G, Wang G, Zhang W, Ma X. Immunophilin FK506 loaded in chitosan guide promotes peripheral nerve regeneration. Biotechnol Lett 2010; 32: 1333-1337.
11. Jost SC, Doolabh VB, Mackinnon SE, Lee M, Hunter D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor Neurol Neurosci 2000; 17: 39-44.
12. Chunasuwankul R, Ayrout C, Dereli Z, Gal A, Lanzetta M, Owen E. Low dose discontinued FK506 treatment enhances peripheral nerve regeneration. Int Surg 2002; 87: 274-278.
13. Becker DB, Jensen JN, Myckatyn TM, Doolabh VB, Hunter DA, Mackinnon SE. Effects of FKBP-12 ligands following tibial nerve injury in rats. J Reconstr Microsurg 2000; 16: 613-620.
14. Haisheng H, Songjie Z, Xin L. Assessment of nerve regeneration across nerve allografts treated with tacrolimus. Artif Cells Blood Substit Immobil Biotechnol 2008; 36: 465-474.
15. Chabas JF, Alluin O, Rao G, Garcia S, Lavaut MN, Legre R et al. FK506 induces changes in muscle properties and promotes metabosensitive nerve fiber regeneration. J Neurotrauma 2009; 26: 97-108.
16. Chen B, Song Y, Liu Z. Promotion of nerve regeneration in peripheral nerve by shortcourse FK506 after end-to-side neurorrhaphy. J Surg Res 2009; 152: 303-310.
17. Lagoda G, Xie Y, Sezen SF, Hurt KJ, Liu L, Musicki B et al. FK506 neuroprotection after cavernous nerve injury is mediated by thioredoxin and glutathione redox systems. J Sex Med 2011; 8: 3325-3334.
18. Li Q, Shen TG, Wu YM, Li J, Wang G. Experimental study of electrophysiologic effects of regenerative nerve fibres affected by control releasing FK506. China J Orthop Traumatol 2010; 23: 841-844.
19. Que J, Cao Q, Sui T, Du SH, Zhang AL, Kong DC et al. Tacrolimus reduces scar formation and promotes sciatic nerve regeneration. Neural Regen Res 2012; 7: 2500-2506.
20. Kuo YR, Wu WS, Jeng SF, Huang HC, Yang KD, Sacks JM et al. Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed-dye laser treatment. Lasers Surg Med 2005; 36: 31-37.
21. Sun Y, Wang L, Sun S, Liu B, Wu N, Cao. X. The effect of 10-hydroxycamptothecine in preventing fibroblast proliferation and epidural scar adhesion after laminectomy in rats. Eur J Pharmacol 2008; 593: 44-48.
22. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103: 239-252.
23. Jeon SH, Park HM, Kim SJ, Lee MY, Kim GB, Rahman MM et al. Taurine reduces FK506- induced generation of ROS and activation of JNK and Bax in Madin Darby canine kidney cells. Hum Exp Toxicol 2010; 29: 627-633.
24. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-1912.
25. Dougherty CJ, Kubasiak LA, Prentice H, Andreka P, Bishopric NH, Webster KA. Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem J 2002; 362: 561-571.
26. Engelbrecht AM, Niesler C, Page C, Lochner A. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res Cardiol 2004; 99: 338-350.
27. El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, Gandesiri M et al. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 2010; 15: 183-195.
28. Park C, Jin CY, Kim GY, Choi IW, Kwon TK, Choi BT et al. Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK. Toxicol Appl Pharmacol 2008; 227: 219-228.
29. Yang SH, Wu ZZ, Chien CM, Lo YH, Wu MJ, Chang LS et al. JNK and ERK mitogenactivated protein kinases mediate THDA-induced apoptosis in K562 cells. Cell Biol Toxicol 2008; 24: 291-302.
30. Lin KL, Su JC, Chien CM, Tseng CH, Chen YL, Chang LS et al. Naphtho [1,2-b]furan-4,5- dione induces apoptosis and S-phase arrest of MDA-MB-231 cells through JNK and ERK signaling activation. Toxicol In Vitro 2010; 24: 61-70.
31. Eguchi R, Fujimori Y, Takeda H, Tabata C, Ohta T, Kuribayashi K et al. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells. J Cell Physiol 2011; 226: 762-768.
32. van den Brink MR, Kapeller R, Pratt JC, Chang JH, Burakoff SJ. The extracellular signalregulated kinase pathway is required for activation-induced cell death of T cells. J Biol Chem 1999; 274: 11178-11185.
33. Szydlowska K, Gozdz A, Dabrowski M, Zawadzka M, Kaminska B. Prolonged activation of ERK triggers glutamate-induced apoptosis of astrocytes: Neuroprotective effect of FK506. J Neurochem 2010; 113: 904-918.
34. Cai J, Yang J, Jones DP. Mitochondrial control of apoptosis: The role of cytochrome c. Biochim Biophys Acta 1998; 1366: 139-149.
35. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-413.
36. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN et al. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 2001; 22: 1633-1639.
37. Blasinska A, Drobnik J. Effects of nonwoven mats of Di-O-butyrylchitin and related polymers on the process of wound healing. Biomacromolecules 2008; 9: 776-782.